litlas
Log inCreate account

Thomas P. Monath

Active 1973–2024

Also published as
Thomas P Monath
135
Papers
21,102
Citations
91
h-index
133
i10-index

Citations

Citations per year for Thomas P. Monath1974: 3 citations1975: 5 citations1977: 3 citations1978: 1 citations1979: 1 citations1982: 3 citations1983: 5 citations1984: 5 citations1985: 7 citations1986: 36 citations1987: 26 citations1988: 19 citations1989: 16 citations1990: 14 citations1991: 18 citations1992: 19 citations1993: 14 citations1994: 13 citations1995: 26 citations1996: 30 citations1997: 53 citations1998: 67 citations1999: 85 citations2000: 136 citations2001: 193 citations2002: 185 citations2003: 240 citations2004: 180 citations2005: 222 citations2006: 192 citations2007: 183 citations2008: 191 citations2009: 207 citations2010: 200 citations2011: 157 citations2012: 141 citations2013: 150 citations2014: 186 citations2015: 102 citations2016: 108 citations2017: 147 citations2018: 117 citations2019: 548 citations2020: 515 citations2021: 420 citations2022: 294 citations2023: 233 citations2024: 355 citations2025: 157 citations2026: 7 citations1976: no citations, so this year is not shown1980–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,028 citing papers, 29% of this breakdownUnited Kingdom: 438 citing papers, 6.3% of this breakdownFrance: 366 citing papers, 5.2% of this breakdownBrazil: 341 citing papers, 4.9% of this breakdownGermany: 288 citing papers, 4.1% of this breakdownChina: 232 citing papers, 3.3% of this breakdownAustralia: 201 citing papers, 2.9% of this breakdownSwitzerland: 168 citing papers, 2.4% of this breakdownIndia: 162 citing papers, 2.3% of this breakdownCanada: 157 citing papers, 2.3% of this breakdownItaly: 114 citing papers, 1.6% of this breakdownNetherlands: 112 citing papers, 1.6% of this breakdown
0%29%Other 34.1%

Institutions

Fields

  • Medicine79.8%
  • Immunology and Microbiology5.4%
  • Agricultural and Biological Sciences4.6%
  • Biochemistry, Genetics and Molecular Biology4.6%
  • Pharmacology, Toxicology and Pharmaceutics1.3%
  • Chemistry0.9%
  • Other3.4%

Topics

  • Mosquito-borne diseases and control17.8%
  • Viral Infections and Vectors14.1%
  • Viral Infections and Outbreaks Research7.6%
  • Malaria Research and Control5.6%
  • Zoonotic diseases and public health2.3%
  • Viral gastroenteritis research and epidemiology2.2%
  • Other50.4%

Coauthors

All papers

Open in search
  1. Epidemic arboviral diseases: priorities for research and public health

    Authors: Annelies Wilder‐Smith, Duane J. Gubler, Scott C. Weaver, Thomas P. Monath, David L Heymann, Thomas W. Scott - The Lancet Infectious Diseases 2016 cited by 584

  2. Yellow fever

    Authors: Thomas P. Monath, Pedro Fernando da Costa Vasconcelos - Journal of Clinical Virology 2014 cited by 673

  3. Lassa Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra Leone

    Authors: Thomas P. Monath, V. F. Newhouse, Graham E. Kemp, Henry W. Setzer, Anthony Cacciapuoti - Science 1974 cited by 326

  4. Yellow fever: an update

    Authors: Thomas P. Monath - The Lancet Infectious Diseases 2001 cited by 537

  5. Proposed revision to the taxonomy of the genus Pestivirus, family Flaviviridae

    Authors: Donald B. Smith, Gregor Meyers, Jens Bukh, Ernest A. Gould, Thomas P. Monath, A. Scott Muerhoff, Alexander G. Pletnev, Rebecca Rico-Hesse, Jack T. Stapleton, Peter Simmonds, Paul Becher - Journal of General Virology 2017 cited by 332

  6. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine

    Authors: Jason A. Regules, John H. Beigel, Kristopher Paolino, Jocelyn Voell, Amy R. Castellano, Zonghui Hu, P. Rubio Muñoz, James E. Moon, Richard C. Ruck, Jason W. Bennett, Patrick Twomey, Ramiro L. Gutiérrez, Shon Remich, Holly R. Hack, Meagan L. Wisniewski, Matthew Josleyn, Steven A. Kwilas, Nicole Van Deusen, Olivier Tshiani Mbaya, Yan Zhou, Daphne A. Stanley, Jing Wang, Kirsten S. Smith, Meng Shi, Julie E. Ledgerwood, Barney S. Graham, Nancy J. Sullivan, Linda L. Jagodzinski, Sheila A. Peel, Judie B. Alimonti, Jay W. Hooper, Peter Silvera, Brian K. Martin, Thomas P. Monath, W. Jay Ramsey, Charles J. Link, H. Clifford Lane, Nelson L. Michael, Richard T. Davey, Stephen J. Thomas - New England Journal of Medicine 2015 cited by 395

  7. Fever versus fever: The role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus

    Authors: Kathryn A. Hanley, Thomas P. Monath, Scott C. Weaver, Shannan L. Rossi, Rebecca Richman, Nikos Vasilakis - Infection Genetics and Evolution 2013 cited by 215

  8. Vaccines against diseases transmitted from animals to humans: A one health paradigm

    Authors: Thomas P. Monath - Vaccine 2013 cited by 122

  9. Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease

    Authors: Thomas P. Monath, Richard Nichols, Friederike Feldmann, Amanda Griffin, Elaine Haddock, Julie Callison, Kimberly Meade‐White, Atsushi Okumura, Jamie Lovaglio, Patrick W. Hanley, Chad S. Clancy, Carl Shaia, Wasima Rida, Joan Fusco - Frontiers in Immunology 2023 cited by 24

  10. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.

    Authors: Jack D. Poland, Charles H. Calisher, Thomas P. Monath, W. G. Downs, Kevin R. Murphy - 1981 cited by 307

  11. The Origin of COVID-19 and Why It Matters

    Authors: David M. Morens, Joel G. Breman, Charles H. Calisher, Peter C. Doherty, Beatrice H. Hahn, Gerald T. Keusch, Laura D. Kramer, James W. LeDuc, Thomas P. Monath, Jeffery K. Taubenberger - American Journal of Tropical Medicine and Hygiene 2020 cited by 211

  12. A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants

    Authors: Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, Wen-Jiun Peng, Yea-Huei Shen, Be-Sheng Kuo, Juin-Hua Huang, Hope Liu, Yu-Hsin Ho, Feng Lin, Shuang Ding, Zhi Liu, Huan-Ting Wu, Ching-Tai Huang, Yuarn-Jang Lee, Ming-Che Liu, Yi-Ching Yang, Po-Liang Lu, Hung-Chin Tsai, Chen-Hsiang Lee, Zhi-Yuan Shi, Chun-Eng Liu, Chun-Hsing Liao, Feng-Yee Chang, Hsiang-Cheng Chen, Fu-Der Wang, Kuo-Liang Hou, Jennifer Cheng, Min-Sheng Wang, Ya-Ting Yang, Han-Chen Chiu, Ming-Han Jiang, Hao-Yu Shih, Hsuan-Yu Shen, Po-Yen Chang, Yu-Rou Lan, Chi-Tian Chen, Yi-Ling Lin, Jian-Jong Liang, Chun-Che Liao, Yu-Chi Chou, Mary Kate Morris, Carl V. Hanson, Farshad Guirakhoo, Michael Hellerstein, Hui-Jing Yu, Chwan-Chuen King, Tracy Kemp, D. Gray Heppner, Thomas P. Monath - Journal of Clinical Investigation 2022 cited by 77

  13. A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants

    Authors: Chang Yi Wang, Kao‐Pin Hwang, Hui-Kai Kuo, Wen‐Jiun Peng, Yea-Huei Shen, Be-Sheng Kuo, Juin-Hua Huang, Hope Liu, Yu-Hsin Ho, Lin Feng, Shuang Ding, Zhi Liu, Huan‐Ting Wu, Ching‐Tai Huang, Yuarn‐Jang Lee, Ming‐Che Liu, Yi‐Ching Yang, Po‐Liang Lu, Hung‐Chin Tsai, Chen‐Hsiang Lee, Zhi‐Yuan Shi, Chun-Eng Liu, Chun‐Hsing Liao, Feng‐Yee Chang, Hsiang‐Cheng Chen, Fu‐Der Wang, Kuo-Liang Hou, Jennifer Cheng, Min-Sheng Wang, Ya-Ting Yang, Han-Chen Chiu, Ming-Han Jiang, Hao‐Yu Shih, Hsuan-Yu Shen, Po-Yen Chang, Yu-Rou Lan, Chi-Tian Chen, Yi‐Ling Lin, Jian‐Jong Liang, Chun‐Che Liao, Yu‐Chi Chou, Mary Kate Morris, Carl V. Hanson, Farshad Guirakhoo, Michael Hellerstein, Hui Jing Yu, Chwan‐Chuen King, Tracy Kemp, D. Gray Heppner, Thomas P. Monath - 2022 cited by 76

  14. Yellow fever vaccine

    Authors: Thomas P. Monath - Expert Review of Vaccines 2005 cited by 468

  15. Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia

    Authors: Stephen B. Kennedy, Fatorma K. Bolay, Mark Kieh, Greg Grandits, Moses Badio, Ripley W. Ballou, Risa Eckes, Mark B. Feinberg, Dean Follmann, Birgit Grund, Swati Gupta, Lisa E. Hensley, Elizabeth S. Higgs, Krisztina Janosko, Melvin Johnson, Francis Kateh, James Logue, Jonathan Marchand, Thomas P. Monath, Martha Nason, Tolbert Nyenswah, François Roman, Eric Stavale, Julian Wolfson, James D. Neaton, H. Clifford Lane - New England Journal of Medicine 2017 cited by 253

  16. Pathogenesis and Pathophysiology of Yellow Fever

    Authors: Thomas P. Monath, Alan D.T. Barrett - Advances in virus research 2003 cited by 219

  17. Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

    Authors: Thomas P. Monath, Richard Nichols, W. Tad Archambault, Linda W. Moore, Ron Marchesani, Jason Tian, Robert E. Shope, Nicola Thomas, Robert Schrader, Dean Furby, Philip Bedford - American Journal of Tropical Medicine and Hygiene 2002 cited by 177

  18. Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential

    Authors: Thomas P. Monath, Richard Nichols, Lynda Tussey, Kelly Scappaticci, Thaddeus G. Pullano, Mary D. Whiteman, Nikos Vasilakis, Shannan L. Rossi, Rafael K. Campos, Sasha R. Azar, Heidi Spratt, Brent L. Seaton, W. Tad Archambault, Yanina V. Costecalde, Evan H. Moore, Roger Hawks, Joan Fusco - PLoS Pathogens 2022 cited by 26

  19. Yellow fever resurgence: An avoidable crisis?

    Authors: Nicole P. Lindsey, Jennifer Horton, Alan D.T. Barrett, Maurice Demanou, Thomas P. Monath, Oyewale Tomori, Michel Van Herp, H. Zeller, Ibrahima Socé Fall, Laurence Cibrelus, J. Erin Staples - npj Vaccines 2022 cited by 22

  20. The Arboviruses: Epidemiology and Ecology

    Authors: Thomas P. Monath - 2019 cited by 1,249

  21. Dengue: the risk to developed and developing countries.

    Authors: Thomas P. Monath - National Academy of Sciences, Proceedings of the National Academy of Sciences 1994 cited by 785

  22. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

    Authors: Bruno Guy, Farshad Guirakhoo, Véronique Barban, Stephen Higgs, Thomas P. Monath, Jean Lang - Vaccine 2009 cited by 285

  23. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever

    Authors: Emily S. Jentes, Gilles Poumerol, Mark D. Gershman, David R. Hill, Johan Lemarchand, Rosamund Lewis, J. Erin Staples, Oyewale Tomori, Annelies Wilder‐Smith, Thomas P. Monath - The Lancet Infectious Diseases 2011 cited by 261

  24. Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections

    Authors: Thomas P. Monath, Karen McCarthy, Philip Bedford, Casey Johnson, Richard Nichols, Sutee Yoksan, Ron Marchesani, Michael Knauber, Keith H. Wells, Juan Arroyo, Farshad Guirakhoo - Vaccine 2002 cited by 220